Marc van de Casteele

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

A. Haycox, S. Simoens, B. Godman, 2017, Front. Pharmacol..

The use of national reimbursement reports to support formulary decisions of the hospital’s Drug and Therapeutics Committee: a comparative analysis

S. Rottey, B. Claus, S. Commeyne, 2022, International Journal of Clinical Pharmacy.

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

A. Haycox, S. Simoens, B. Godman, 2016, Front. Pharmacol..

Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines

M. Obach, V. Acha, S. Vamvakas, 2020, British journal of clinical pharmacology.

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

A. Haycox, S. Simoens, B. Godman, 2017, Frontiers in Pharmacology.